Aptorum Group Ltd Stock Analysis

Aptorum Stock Analysis Notes

About 24.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.16. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aptorum Group recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 23rd of January 2023. Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Aptorum Group Ltd please contact Darren Lui at 44 20 8092 9299 or go to https://www.aptorumgroup.com.

Aptorum Group Investment Alerts

Aptorum Group Upcoming and Recent Events

Aptorum Largest EPS Surprises

View All Earnings Estimates

Aptorum Stock Institutional Investors

Note, although Aptorum Group's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aptorum Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 3.97 M.

Aptorum Profitablity

Management Efficiency

Aptorum Group has Return on Asset of (0.323) % which means that on every $100 spent on assets, it lost $0.323. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.374) %, meaning that it generated no profit with money invested by stockholders. Aptorum Group's management efficiency ratios could be used to measure how well Aptorum Group manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -0.14. In addition to that, Return On Capital Employed is likely to drop to -0.6. At this time, Aptorum Group's Total Assets are very stable compared to the past year. As of the 30th of November 2024, Net Tangible Assets is likely to grow to about 31 M, while Non Current Assets Total are likely to drop about 15 M.

Technical Drivers

As of the 30th of November, Aptorum Group shows the Risk Adjusted Performance of (0.18), standard deviation of 8.07, and Mean Deviation of 4.73. Aptorum Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aptorum Group market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Aptorum Group is priced correctly, providing market reflects its regular price of 0.65 per share. As Aptorum Group is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Aptorum Group Price Movement Analysis

Aptorum Group Outstanding Bonds

Aptorum Group Predictive Daily Indicators

Aptorum Group Forecast Models

Aptorum Group's time-series forecasting models are one of many Aptorum Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aptorum Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aptorum Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aptorum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aptorum Group. By using and applying Aptorum Stock analysis, traders can create a robust methodology for identifying Aptorum entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aptorum analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aptorum analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Aptorum Group Ltd stock analysis indicators help investors evaluate how Aptorum Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aptorum Group shares will generate the highest return on investment. By understating and applying Aptorum Group stock analysis, traders can identify Aptorum Group position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptorum Group Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.